Novel tetravalent antibodies for the ultrapotent and broad neutralization of SARS-CoV-2 variants

By | November 9, 2021
Researchers from the University of Toronto set out to create a new tetravalent antibody that could bind with enough potency that it could remain effective against VOCs.